Obulytix has had an exciting start to the year, marked by important milestones and strengthening the contribution to the fight against antimicrobial resistance. Obulytix joined the END2AMR consortium, a new Innovative Health Initiative (IHI)-supported collaboration [...]
More news
Just before turning the page to 2026, it’s worth pausing to reflect on both the [...]
The INCATE Management team is happy to announce the release of INCATE’s first report, covering [...]
A collaborative research program led by the Helmholtz Centre for Infection Research (HZI) in Braunschweig, [...]
Couldn’t make it to our latest Entrepreneurs Club session, or want to revisit the discussion? [...]
The INCATE Team is happy to share some exciting news: the INCATE Selection Committee has [...]
Over the past four years, INCATE has been supporting early-stage ventures working on innovations to [...]
Unison Medicines is delighted to announce an oversubscribed first close of $500k of financing from [...]
We are happy to announce a new partnership with Granzer Regulatory Consulting & Services GmbH [...]
